Inventor · disambiguated record
Bailing Yang
Also filed as: YANG BAILING
10 granted patents·13 pending applications·36 citations·filing 2015–2025
85Inventor score
Files withASCLETIS BIOSCIENCE CO LTD10ASCLETIS PHARMA CHINA CO LTD7GANNEX PHARMA CO LTD4JIANGSU KANION PARMACEUTICAL CO LTD1JIANGSU KANION PHARMACEUTICAL CO LTD1
Top patents by PatentIndex Score
23 records- 0195US11541071B1Nucleoside derivatives and methods of use thereofASCLETIS BIOSCIENCE CO LTD·Filed 2022·Granted Jan 3, 2023·23 cites·20 claims
- 0294US12234236B1GLP-1R agonist and therapeutic method thereofASCLETIS PHARMA CHINA CO LTD·Filed 2024·Granted Feb 25, 2025·3 cites·25 claims
- 0394US11292805B2Preparation method of a cyclic phosphonate compoundGANNEX PHARMA CO LTD·Filed 2021·Granted Apr 5, 2022·4 cites·14 claims
- 0493US11725019B2Preparation method of a cyclic phosphonate compoundGANNEX PHARMA CO LTD·Filed 2022·Granted Aug 15, 2023·2 cites·12 claims
- 0589US12291530B1GLP-1R agonist and therapeutic method thereofASCLETIS PHARMA CHINA CO LTD·Filed 2024·Granted May 6, 2025·1 cites·13 claims
- 0683US12084469B2Preparation method of a cyclic phosphonate compoundGANNEX PHARMA CO LTD·Filed 2023·Granted Sep 10, 2024·0 cites·16 claims
- 0783US2025346594A1GLP-1R Agonist and Therapeutic Method ThereofASCLETIS PHARMA CHINA CO LTD·Filed 2025·Application pending·0 cites
- 0883US2025346596A1GLP-1R Agonist and Therapeutic Method ThereofASCLETIS PHARMA CHINA CO LTD·Filed 2025·Application pending·0 cites
- 0983US2025346595A1GLP-1R Agonist and Therapeutic Method ThereofASCLETIS PHARMA CHINA CO LTD·Filed 2025·Application pending·0 cites
- 1076US2024189337A1Nucleoside derivatives and methods of use thereofASCLETIS BIOSCIENCE CO LTD·Filed 2023·Application pending·0 cites
- 1175US11865132B2Nucleoside derivatives and methods of use thereofASCLETIS BIOSCIENCE CO LTD·Filed 2022·Granted Jan 9, 2024·0 cites·11 claims
- 1275US9988361B2Anti-enterovirus 71 thiadiazolidine derivativeJIANGSU KANION PHARMACEUTICAL CO LTD·Filed 2015·Granted Jun 5, 2018·2 cites·7 claims
- 1373US2025376470A1GLP-1R Agonist and Therapeutic Method ThereofASCLETIS PHARMA CHINA CO LTD·Filed 2025·Application pending·0 cites
- 1469US2023234921A1Inhibitors of cysteine proteases and methods of use thereofASCLETIS BIOSCIENCE CO LTD·Filed 2023·Application pending·0 cites
- 1567US10227339B2Salt form and crystal form of 1,2,5-thiadiazolidin-1,1-dioxide, preparation method thereof and intermediateJIANGSU KANION PARMACEUTICAL CO LTD·Filed 2016·Granted Mar 12, 2019·1 cites·8 claims
- 1666US11760722B2Inhibitors of cysteine proteases and methods of use thereofASCLETIS BIOSCIENCE CO LTD·Filed 2022·Granted Sep 19, 2023·0 cites·4 claims
- 1765US2025011303A1Small molecule modulators of il-17a, methods of making and methods of using thereofASCLETIS BIOSCIENCE CO LTD·Filed 2024·Application pending·0 cites
- 1865US2024327428A1Inhibitors of human immunodeficiency virus replication, method of making and method of using thereofASCLETIS BIOSCIENCE CO LTD·Filed 2024·Application pending·0 cites
- 1959US2025257062A1GLP-1R Agonist and Therapeutic Method ThereofASCLETIS PHARMA CHINA CO LTD·Filed 2025·Application pending·0 cites
- 2059US2023271949A1Glp-1r modulating compoundsASCLETIS BIOSCIENCE CO LTD·Filed 2022·Application pending·0 cites
- 2153US2025340529A1Heterocyclic Compounds as Immunomodulators of PD-L1 InteractionsASCLETIS BIOSCIENCE CO LTD·Filed 2021·Application pending·0 cites
- 2250US2023165843A1Use and pharmaceutical composition of phenylisoxazolyl methylene-naphthalene-ether derivativesGANNEX PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 2340US2021038681A1Pharmaceutical composition for treating viral hepatitis cASCLETIS BIOSCIENCE CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Bailing Yang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →